|
市場調査レポート
商品コード
1517254
トランスフェクション技術の世界市場 2024-2028Global transfection technologies market 2024-2028 |
||||||
|
|
|||||||
カスタマイズ可能
|
|||||||
価格
| トランスフェクション技術の世界市場 2024-2028 |
|
出版日: 2024年05月21日
発行: TechNavio
ページ情報: 英文 172 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
概要
トランスフェクション技術市場は2023-2028年に6億7,590万米ドル、予測期間中のCAGRは9.66％で成長すると予測されます。
当レポートでは、トランスフェクション技術市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、モノクローナル抗体に対する需要の高まり、市場ベンダーによるトランスフェクション技術の継続的開拓、CRISPR/CAS9遺伝子編集技術の採用拡大などが牽引しています。
| 市場範囲 | |
|---|---|
| 基準年 | 2024 |
| 終了年 | 2028 |
| 予測期間 | 2024-2028 |
| 成長モメンタム | 加速 |
| 前年比2024年 | 9.45% |
| CAGR | 9.66% |
| 増分額 | 6億7,590万米ドル |
本調査では、今後数年間のトランスフェクション技術市場成長を牽引する主な要因の1つとして、デュアルレポーターアッセイとコ・トランスフェクション実験の利用の増加を挙げています。また、トランスフェクション効率の最適化とハイスループット・トランスフェクション・スクリーニングへの注目の高まりは、市場の大きな需要につながります。
目次
第1章 エグゼクティブサマリー
- 市場概要
第2章 市場情勢
- 市場エコシステム
- 市場の特徴
- バリューチェーン分析
第3章 市場規模の評価
- 市場の定義
- 市場セグメント分析
- 市場規模 2023
- 市場の見通し 2023-2028
第4章 市場規模実績
- 世界トランスフェクション技術市場 2018-2022
- タイプ別セグメント分析 2018-2022
- エンドユーザー別セグメント分析 2018-2022
- 地域別セグメント分析 2018-2022
- 国別セグメント分析 2018-2022
第5章 ファイブフォース分析
- ファイブフォースの要約
- 買い手の交渉力
- 供給企業の交渉力
- 新規参入業者の脅威
- 代替品の脅威
- 競争の脅威
- 市況
第6章 市場セグメンテーション：タイプ別
- 市場セグメンテーション
- 比較：タイプ別
- ウイルスベクターベースのトランスフェクション：市場規模と予測 2023-2028
- 物理的トランスフェクション：市場規模と予測 2023-2028
- 生化学に基づくトランスフェクション：市場規模と予測 2023-2028
- 市場機会：タイプ別
第7章 市場セグメンテーション：エンドユーザー別
- 市場セグメンテーション
- 比較：エンドユーザー別
- 製薬・バイオテクノロジー企業：市場規模と予測 2023-2028
- 委託調査機関：市場規模と予測 2023-2028
- 学術研究機関：市場規模と予測 2023-2028
- 市場機会：エンドユーザー別
第8章 顧客情勢
- 顧客情勢の概要
第9章 地域別情勢
- 地域別セグメンテーション
- 地域別比較
- 北米：市場規模と予測 2023-2028
- 欧州：市場規模と予測 2023-2028
- アジア：市場規模と予測 2023-2028
- 世界のその他の地域：市場規模と予測 2023-2028
- 米国：市場規模と予測 2023-2028
- 中国：市場規模と予測 2023-2028
- 英国：市場規模と予測 2023-2028
- ドイツ：市場規模と予測 2023-2028
- フランス：市場規模と予測 2023-2028
- 市場機会：地域情勢別
第10章 促進要因・課題・機会・抑制要因
- 市場促進要因
- 市場の課題
- 促進要因と課題の影響
- 市場の機会・抑制要因
第11章 競合情勢
- 概要
- 競合情勢
- 混乱の状況
- 業界のリスク
第12章 競合分析
- 企業プロファイル
- 企業の市場ポジショニング
- Altogen Biosystems
- Bio Rad Laboratories Inc.
- Danaher Corp.
- GENLANTIS
- Lonza Group Ltd.
- MaxCyte Inc.
- Merck KGaA
- Mirus Bio LLC
- OZ Biosciences
- Promega Corp.
- QIAGEN NV
- Sartorius AG
- SignaGen Laboratories
- Takara Holdings Inc.
- Thermo Fisher Scientific Inc.
第13章 付録
図表
Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by Type
- Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
- Exhibits7: Executive Summary - Chart on Incremental Growth
- Exhibits8: Executive Summary - Data Table on Incremental Growth
- Exhibits9: Executive Summary - Chart on Company Market Positioning
- Exhibits10: Parent Market
- Exhibits11: Data Table on - Parent Market
- Exhibits12: Market characteristics analysis
- Exhibits13: Value Chain Analysis
- Exhibits14: Offerings of companies included in the market definition
- Exhibits15: Market segments
- Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits20: Historic Market Size - Data Table on Global Transfection Technologies Market 2018 - 2022 ($ million)
- Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
- Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
- Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
- Exhibits25: Five forces analysis - Comparison between 2023 and 2028
- Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
- Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
- Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
- Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
- Exhibits31: Chart on Market condition - Five forces 2023 and 2028
- Exhibits32: Chart on Type - Market share 2023-2028 (%)
- Exhibits33: Data Table on Type - Market share 2023-2028 (%)
- Exhibits34: Chart on Comparison by Type
- Exhibits35: Data Table on Comparison by Type
- Exhibits36: Chart on Viral-vector based transfection - Market size and forecast 2023-2028 ($ million)
- Exhibits37: Data Table on Viral-vector based transfection - Market size and forecast 2023-2028 ($ million)
- Exhibits38: Chart on Viral-vector based transfection - Year-over-year growth 2023-2028 (%)
- Exhibits39: Data Table on Viral-vector based transfection - Year-over-year growth 2023-2028 (%)
- Exhibits40: Chart on Physical transfection - Market size and forecast 2023-2028 ($ million)
- Exhibits41: Data Table on Physical transfection - Market size and forecast 2023-2028 ($ million)
- Exhibits42: Chart on Physical transfection - Year-over-year growth 2023-2028 (%)
- Exhibits43: Data Table on Physical transfection - Year-over-year growth 2023-2028 (%)
- Exhibits44: Chart on Biochemical based transfection - Market size and forecast 2023-2028 ($ million)
- Exhibits45: Data Table on Biochemical based transfection - Market size and forecast 2023-2028 ($ million)
- Exhibits46: Chart on Biochemical based transfection - Year-over-year growth 2023-2028 (%)
- Exhibits47: Data Table on Biochemical based transfection - Year-over-year growth 2023-2028 (%)
- Exhibits48: Market opportunity by Type ($ million)
- Exhibits49: Data Table on Market opportunity by Type ($ million)
- Exhibits50: Chart on End-user - Market share 2023-2028 (%)
- Exhibits51: Data Table on End-user - Market share 2023-2028 (%)
- Exhibits52: Chart on Comparison by End-user
- Exhibits53: Data Table on Comparison by End-user
- Exhibits54: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Exhibits55: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Exhibits56: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- Exhibits57: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- Exhibits58: Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million)
- Exhibits59: Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million)
- Exhibits60: Chart on Contract research organizations - Year-over-year growth 2023-2028 (%)
- Exhibits61: Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%)
- Exhibits62: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
- Exhibits63: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
- Exhibits64: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
- Exhibits65: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
- Exhibits66: Market opportunity by End-user ($ million)
- Exhibits67: Data Table on Market opportunity by End-user ($ million)
- Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits71: Chart on Geographic comparison
- Exhibits72: Data Table on Geographic comparison
- Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
- Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
- Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
- Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
- Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits105: Chart on France - Market size and forecast 2023-2028 ($ million)
- Exhibits106: Data Table on France - Market size and forecast 2023-2028 ($ million)
- Exhibits107: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibits108: Data Table on France - Year-over-year growth 2023-2028 (%)
- Exhibits109: Market opportunity By Geographical Landscape ($ million)
- Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million)
- Exhibits111: Impact of drivers and challenges in 2023 and 2028
- Exhibits112: Overview on criticality of inputs and factors of differentiation
- Exhibits113: Overview on factors of disruption
- Exhibits114: Impact of key risks on business
- Exhibits115: Companies covered
- Exhibits116: Matrix on companies position and classification
- Exhibits117: Altogen Biosystems - Overview
- Exhibits118: Altogen Biosystems - Product / Service
- Exhibits119: Altogen Biosystems - Key offerings
- Exhibits120: Bio Rad Laboratories Inc. - Overview
- Exhibits121: Bio Rad Laboratories Inc. - Business segments
- Exhibits122: Bio Rad Laboratories Inc. - Key news
- Exhibits123: Bio Rad Laboratories Inc. - Key offerings
- Exhibits124: Bio Rad Laboratories Inc. - Segment focus
- Exhibits125: Danaher Corp. - Overview
- Exhibits126: Danaher Corp. - Business segments
- Exhibits127: Danaher Corp. - Key news
- Exhibits128: Danaher Corp. - Key offerings
- Exhibits129: Danaher Corp. - Segment focus
- Exhibits130: GENLANTIS - Overview
- Exhibits131: GENLANTIS - Product / Service
- Exhibits132: GENLANTIS - Key offerings
- Exhibits133: Lonza Group Ltd. - Overview
- Exhibits134: Lonza Group Ltd. - Business segments
- Exhibits135: Lonza Group Ltd. - Key news
- Exhibits136: Lonza Group Ltd. - Key offerings
- Exhibits137: Lonza Group Ltd. - Segment focus
- Exhibits138: MaxCyte Inc. - Overview
- Exhibits139: MaxCyte Inc. - Product / Service
- Exhibits140: MaxCyte Inc. - Key offerings
- Exhibits141: Merck KGaA - Overview
- Exhibits142: Merck KGaA - Business segments
- Exhibits143: Merck KGaA - Key news
- Exhibits144: Merck KGaA - Key offerings
- Exhibits145: Merck KGaA - Segment focus
- Exhibits146: Mirus Bio LLC - Overview
- Exhibits147: Mirus Bio LLC - Product / Service
- Exhibits148: Mirus Bio LLC - Key offerings
- Exhibits149: OZ Biosciences - Overview
- Exhibits150: OZ Biosciences - Product / Service
- Exhibits151: OZ Biosciences - Key offerings
- Exhibits152: Promega Corp. - Overview
- Exhibits153: Promega Corp. - Product / Service
- Exhibits154: Promega Corp. - Key offerings
- Exhibits155: QIAGEN NV - Overview
- Exhibits156: QIAGEN NV - Product / Service
- Exhibits157: QIAGEN NV - Key news
- Exhibits158: QIAGEN NV - Key offerings
- Exhibits159: Sartorius AG - Overview
- Exhibits160: Sartorius AG - Business segments
- Exhibits161: Sartorius AG - Key news
- Exhibits162: Sartorius AG - Key offerings
- Exhibits163: Sartorius AG - Segment focus
- Exhibits164: SignaGen Laboratories - Overview
- Exhibits165: SignaGen Laboratories - Product / Service
- Exhibits166: SignaGen Laboratories - Key offerings
- Exhibits167: Takara Holdings Inc. - Overview
- Exhibits168: Takara Holdings Inc. - Business segments
- Exhibits169: Takara Holdings Inc. - Key offerings
- Exhibits170: Takara Holdings Inc. - Segment focus
- Exhibits171: Thermo Fisher Scientific Inc. - Overview
- Exhibits172: Thermo Fisher Scientific Inc. - Business segments
- Exhibits173: Thermo Fisher Scientific Inc. - Key news
- Exhibits174: Thermo Fisher Scientific Inc. - Key offerings
- Exhibits175: Thermo Fisher Scientific Inc. - Segment focus
- Exhibits176: Inclusions checklist
- Exhibits177: Exclusions checklist
- Exhibits178: Currency conversion rates for US$
- Exhibits179: Research methodology
- Exhibits180: Information sources
- Exhibits181: Data validation
- Exhibits182: Validation techniques employed for market sizing
- Exhibits183: Data synthesis
- Exhibits184: 360 degree market analysis
- Exhibits185: List of abbreviations
目次
Product Code: IRTNTR74402
The transfection technologies market is forecasted to grow by USD 675.9 mn during 2023-2028, accelerating at a CAGR of 9.66% during the forecast period. The report on the transfection technologies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for monoclonal antibodies, continued developments in transfection technologies by market vendors, and growing adoption of CRISPR/CAS9 gene editing technology.
Technavio's transfection technologies market is segmented as below:
| Market Scope | |
|---|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 9.45% |
| CAGR | 9.66% |
| Incremental Value | $675.9mn |
By Type
- Viral-vector based transfection
- Physical transfection
- Biochemical based transfection
By End-user
- Pharmaceutical and biotechnology companies
- Contract research organizations
- Academic and research institutes
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increased use of dual-reporter assays and co-transfection experiments as one of the prime reasons driving the transfection technologies market growth during the next few years. Also, optimization of transfection efficiency and growing focus on high-throughput transfection screening will lead to sizable demand in the market.
The report on the transfection technologies market covers the following areas:
- Transfection technologies market sizing
- Transfection technologies market forecast
- Transfection technologies market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transfection technologies market vendors that include Altogen Biosystems, Bio RAD Laboratories Inc., Danaher Corp., F. Hoffmann La Roche Ltd., GENLANTIS, ibidi GmbH, Inovio Pharmaceuticals Inc., Kytopen Corp., Life Technologies India Pvt Ltd., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, Promega Corp., QIAGEN NV, RJH BIOSCIENCES, Sartorius AG, SignaGen Laboratories, STEMCELL Technologies Inc., Takara Holdings Inc., and Thermo Fisher Scientific Inc.. Also, the transfection technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
- Value Chain Analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Transfection Technologies Market 2018 - 2022
- Historic Market Size - Data Table on Global Transfection Technologies Market 2018 - 2022 ($ million)
- 4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 4.3 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
- 6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
- 6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 6.3 Viral-vector based transfection - Market size and forecast 2023-2028
- Chart on Viral-vector based transfection - Market size and forecast 2023-2028 ($ million)
- Data Table on Viral-vector based transfection - Market size and forecast 2023-2028 ($ million)
- Chart on Viral-vector based transfection - Year-over-year growth 2023-2028 (%)
- Data Table on Viral-vector based transfection - Year-over-year growth 2023-2028 (%)
- 6.4 Physical transfection - Market size and forecast 2023-2028
- Chart on Physical transfection - Market size and forecast 2023-2028 ($ million)
- Data Table on Physical transfection - Market size and forecast 2023-2028 ($ million)
- Chart on Physical transfection - Year-over-year growth 2023-2028 (%)
- Data Table on Physical transfection - Year-over-year growth 2023-2028 (%)
- 6.5 Biochemical based transfection - Market size and forecast 2023-2028
- Chart on Biochemical based transfection - Market size and forecast 2023-2028 ($ million)
- Data Table on Biochemical based transfection - Market size and forecast 2023-2028 ($ million)
- Chart on Biochemical based transfection - Year-over-year growth 2023-2028 (%)
- Data Table on Biochemical based transfection - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by End-user
- 7.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
- 7.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
- Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- 7.4 Contract research organizations - Market size and forecast 2023-2028
- Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million)
- Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million)
- Chart on Contract research organizations - Year-over-year growth 2023-2028 (%)
- Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%)
- 7.5 Academic and research institutes - Market size and forecast 2023-2028
- Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
- Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
- Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
- Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
- 7.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- Companies covered
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 Altogen Biosystems
- Altogen Biosystems - Overview
- Altogen Biosystems - Product / Service
- Altogen Biosystems - Key offerings
- 12.4 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- 12.5 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- 12.6 GENLANTIS
- GENLANTIS - Overview
- GENLANTIS - Product / Service
- GENLANTIS - Key offerings
- 12.7 Lonza Group Ltd.
- Lonza Group Ltd. - Overview
- Lonza Group Ltd. - Business segments
- Lonza Group Ltd. - Key news
- Lonza Group Ltd. - Key offerings
- Lonza Group Ltd. - Segment focus
- 12.8 MaxCyte Inc.
- MaxCyte Inc. - Overview
- MaxCyte Inc. - Product / Service
- MaxCyte Inc. - Key offerings
- 12.9 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- 12.10 Mirus Bio LLC
- Mirus Bio LLC - Overview
- Mirus Bio LLC - Product / Service
- Mirus Bio LLC - Key offerings
- 12.11 OZ Biosciences
- OZ Biosciences - Overview
- OZ Biosciences - Product / Service
- OZ Biosciences - Key offerings
- 12.12 Promega Corp.
- Promega Corp. - Overview
- Promega Corp. - Product / Service
- Promega Corp. - Key offerings
- 12.13 QIAGEN NV
- QIAGEN NV - Overview
- QIAGEN NV - Product / Service
- QIAGEN NV - Key news
- QIAGEN NV - Key offerings
- 12.14 Sartorius AG
- Sartorius AG - Overview
- Sartorius AG - Business segments
- Sartorius AG - Key news
- Sartorius AG - Key offerings
- Sartorius AG - Segment focus
- 12.15 SignaGen Laboratories
- SignaGen Laboratories - Overview
- SignaGen Laboratories - Product / Service
- SignaGen Laboratories - Key offerings
- 12.16 Takara Holdings Inc.
- Takara Holdings Inc. - Overview
- Takara Holdings Inc. - Business segments
- Takara Holdings Inc. - Key offerings
- Takara Holdings Inc. - Segment focus
- 12.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- Research methodology
- 13.5 Data procurement
- Information sources
- 13.6 Data validation
- Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- Data synthesis
- 13.9 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
- List of abbreviations
